JPWO2021139780A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021139780A5 JPWO2021139780A5 JP2022542269A JP2022542269A JPWO2021139780A5 JP WO2021139780 A5 JPWO2021139780 A5 JP WO2021139780A5 JP 2022542269 A JP2022542269 A JP 2022542269A JP 2022542269 A JP2022542269 A JP 2022542269A JP WO2021139780 A5 JPWO2021139780 A5 JP WO2021139780A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- heavy chain
- sequence shown
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020071336 | 2020-01-10 | ||
| CNPCT/CN2020/071336 | 2020-01-10 | ||
| PCT/CN2021/070907 WO2021139780A1 (en) | 2020-01-10 | 2021-01-08 | Anti-tigit antibodies, multispecific antibodies comprising the same and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509215A JP2023509215A (ja) | 2023-03-07 |
| JP2023509215A5 JP2023509215A5 (https=) | 2024-01-16 |
| JPWO2021139780A5 true JPWO2021139780A5 (https=) | 2024-01-16 |
Family
ID=76787751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542269A Pending JP2023509215A (ja) | 2020-01-10 | 2021-01-08 | 抗ｔｉｇｉｔ抗体、それを含む多重特異性抗体及びその使用方法。 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230060388A1 (https=) |
| EP (1) | EP4087877A4 (https=) |
| JP (1) | JP2023509215A (https=) |
| KR (1) | KR20220131261A (https=) |
| CN (1) | CN115023442A (https=) |
| AU (1) | AU2021206421A1 (https=) |
| BR (1) | BR112022013403A2 (https=) |
| CA (1) | CA3164282A1 (https=) |
| WO (1) | WO2021139780A1 (https=) |
| ZA (1) | ZA202208799B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202216778A (zh) | 2020-07-15 | 2022-05-01 | 美商安進公司 | Ｔｉｇｉｔ及ｃｄ１１２ｒ阻斷 |
| WO2023064909A1 (en) * | 2021-10-14 | 2023-04-20 | Nighthawk Biosciences, Inc. | Bifunctional anti-pathogenic agents |
| EP4605002A1 (en) * | 2022-10-17 | 2025-08-27 | BeiGene Switzerland GmbH | Formulations containing anti-tigit antibody and methods of use thereof |
| CN118420712A (zh) * | 2023-02-01 | 2024-08-02 | 上海健信生物医药科技有限公司 | 一种三特异性抗体技术平台及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016115274A1 (en) * | 2015-01-14 | 2016-07-21 | Compass Therapeutics Llc | Multispecific immunomodulatory antigen-binding constructs |
| WO2018052818A1 (en) * | 2016-09-16 | 2018-03-22 | Henlix, Inc. | Anti-pd-1 antibodies |
| JP7348899B2 (ja) * | 2017-12-08 | 2023-09-21 | マレンゴ・セラピューティクス，インコーポレーテッド | 多重特異性分子及びその使用 |
| TW201930358A (zh) * | 2017-12-28 | 2019-08-01 | 大陸商南京傳奇生物科技有限公司 | 針對ｔｉｇｉｔ之單域抗體及其變異體 |
| WO2019134710A1 (en) * | 2018-01-08 | 2019-07-11 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| CN112739717B (zh) * | 2018-06-29 | 2025-02-11 | 璟尚生物制药公司 | 三特异性拮抗剂 |
| CN110818795B (zh) * | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
-
2021
- 2021-01-08 WO PCT/CN2021/070907 patent/WO2021139780A1/en not_active Ceased
- 2021-01-08 AU AU2021206421A patent/AU2021206421A1/en active Pending
- 2021-01-08 BR BR112022013403A patent/BR112022013403A2/pt unknown
- 2021-01-08 CN CN202180008449.0A patent/CN115023442A/zh active Pending
- 2021-01-08 CA CA3164282A patent/CA3164282A1/en active Pending
- 2021-01-08 JP JP2022542269A patent/JP2023509215A/ja active Pending
- 2021-01-08 KR KR1020227027449A patent/KR20220131261A/ko not_active Withdrawn
- 2021-01-08 EP EP21738109.4A patent/EP4087877A4/en not_active Withdrawn
-
2022
- 2022-07-08 US US17/811,513 patent/US20230060388A1/en active Pending
- 2022-08-05 ZA ZA2022/08799A patent/ZA202208799B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022101693A5 (https=) | ||
| JP2021534096A5 (https=) | ||
| JP2024056687A5 (https=) | ||
| JPWO2021139777A5 (https=) | ||
| JP2015509947A5 (https=) | ||
| JP2015509948A5 (https=) | ||
| JP2010524435A5 (https=) | ||
| JPWO2021213434A5 (https=) | ||
| JP2026041845A5 (https=) | ||
| JP2021522347A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2023037000A5 (https=) | ||
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 | |
| JPWO2020139926A5 (https=) | ||
| JP2024020436A5 (https=) | ||
| CN114450025A (zh) | 使用包含多重酪氨酸激酶抑制剂和免疫检查点抑制剂的组合治疗癌症 | |
| JPWO2022111425A5 (https=) | ||
| JPWO2021139776A5 (https=) | ||
| JP2025130076A5 (https=) | ||
| JPWO2019201959A5 (https=) | ||
| JPWO2021139780A5 (https=) | ||
| JPWO2019210848A5 (https=) | ||
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use | |
| JPWO2022068854A5 (https=) | ||
| JPWO2022207822A5 (https=) |